Spruce Biosciences, Inc. SPRB
46.61 USD +3.80 (+8.88%)
At closeNov 4, 2026, 4:00 PM EST
46.61 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
44.43 Day range 46.61
38.06 52-week range 129.00
- YTD
- -46.49%
- 1 year
- -55.58%
Financial health
Altman Z-Score
-0.66 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
Valuation
P/E -1.7×
FY 2018 5y median -1.7× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 1.6×
FY 2018 5y median 1.4× FY 2025
P/FCF -2.0×
FY 2018 5y median -2.0× FY 2025
EV/EBITDA -0.5×
FY 2018 5y median -0.5× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -49.9%
FY 2018 5y median -49.9% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -91.7%
FY 2018 5y median -67.4% FY 2025
ROIC -84.4%
FY 2018 5y median -63.9% FY 2025
ROA -73.5%
FY 2018 5y median -53.9% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2018 FY 2025
Operating Income 35.0%
FY 2018 FY 2025
EPS (diluted) 47.5%
FY 2018 FY 2025
Free Cash Flow 40.4%
FY 2018 FY 2025
Financial Health
Current Ratio 5.2×
FY 2018 5y median 5.2× FY 2025
Quick Ratio 5.2×
FY 2018 5y median 5.2× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 1.2×
FY 2018 5y median 0.9× FY 2025
Interest Coverage -406×
FY 2018 5y median -122× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31